VASCULAR ACCESS DEVICES, SYSTEMS, AND METHODS FOR MONITORING PATIENT HEALTH
Vascular access assemblies are disclosed herein. In one example, a vascular access assembly comprises a proximal catheter, a distal catheter, and a junction positioned between the proximal and distal catheters and configured to position the proximal and distal catheters in fluid communication. The junction may comprise one or more sensors configured to obtain physiological and/or operational measurements. The junction may be configured to wirelessly transmit the measurements to one or more local or remote computing devices for monitoring by a caregiver.
1 - 13 . (canceled)
14 . A vascular access assembly (“VAA”), comprising:
an extension tube having a proximal end and a distal end;
a catheter having a proximal end and a distal end, the distal end configured to be positioned in a blood vessel of a patient;
a junction having an inflow region coupled to a distal end of the extension tube and an outflow region coupled to a proximal end of the catheter, wherein the junction is configured to fluidly couple the extension tube and the catheter;
a sensor configured to obtain measurements; and
at least one controller configured to be communicatively coupled to the sensor, wherein the at least one controller is further configured to—
obtain the measurements via the sensor while the catheter is positioned within the blood vessel; and
determine at least one physiological parameter based on the measurements.
15 . The VAA of claim 14 , wherein sensor is disposed at an interior region of the junction.
16 . The VAA of claim 14 , wherein the sensor is disposed at an exterior region of the junction.
17 . The VAA of claim 14 , wherein the sensor comprises a first sensor at an exterior region of the junction and a second sensor at an interior region of the junction.
18 . The VAA of claim 14 , wherein the sensor is disposed within a lumen of the extension tube.
19 . The VAA of claim 14 , wherein the sensor is disposed within a lumen of the catheter.
20 . The VAA of claim 14 , wherein the sensor is disposed within a wall of the catheter.
21 . The VAA of claim 14 , wherein the junction is a portion of a central venous catheter, a midline catheter, a peripherally-inserted central catheter, a peripheral intravenous line, or an arterial line catheter.
22 . The VAA of claim 14 , wherein at least a portion of the sensor is exposed at an exterior surface of the junction such that, when the junction is positioned against a patient's skin, the sensor is in contact with the patient's skin.
23 . The VAA of claim 14 , wherein the sensor comprises a plurality of sensors.
24 . The VAA of claim 23 , wherein each of the plurality of sensors have a portion that is exposed at an exterior surface of the junction such that, when the junction is positioned against a patient's skin, each of the sensors is in contact with the patient's skin.
25 . The VAA of claim 23 , wherein at least one of the sensors is disposed at an exterior surface of the junction and at least one of the sensors is disposed at an interior region of the junction.
26 . The VAA of claim 14 , wherein the junction is a unitary body formed of a heat molded material.
27 . The VAA of claim 14 , wherein the junction includes a first sensor adjacent the inflow region and a second sensor adjacent the outflow region.
28 . The VAA of claim 14 , wherein the junction includes an opening at the inflow region configured to receive a portion of a tubular shaft therethrough.
29 . (canceled)
30 . The VAA of claim 14 , wherein the inflow region includes a receiving region surrounded by a body of the junction, wherein the receiving region is configured to permanently or detachably receive a portion of a tubular shaft therein.
31 . (canceled)
32 . The VAA of claim 14 , wherein the junction is configured to be extracorporeally positioned during use.
33 . The VAA of claim 14 , wherein the at least one controller is configured to compare the at least one physiological parameter to a predetermined threshold.
34 . The VAA of claim 33 , wherein, the at least one controller is configured to provide an indication of the patient's health based on the comparison.
35 . The VAA of claim 33 , wherein, based on the comparison, the controller is configured to provide an indication of a health condition of a patient, the health condition being at least one of sepsis, pulmonary embolism, metastatic spinal cord compression, anemia, dehydration/volume depletion, vomiting, pneumonia, congestive heart failure, kidney failure, volume overload, performance status, arrythmia, neutropenic fever, acute myocardial infarction, pain, opioid toxicity, hyperglycemic/diabetic ketoacidosis, hypoglycemia, hyperkalemia, hypercalcemia, hyponatremia, one or more brain metastases, superior vena cava syndrome, gastrointestinal hemorrhage, immunotherapy-induced or radiation pneumonitis, immunotherapy-induced colitis, diarrhea, cerebrovascular accident, stroke, pathological fracture, hemoptysis, hematemesis, medication-induced QT prolongation, heart block, tumor lysis syndrome, sickle cell anemia crisis, gastroparesis/cyclic vomiting syndrome, hemophilia, cystic fibrosis, chronic pain, and seizure.
36 - 56 . (canceled)